Weight Loss
Prefer to explore an under-the-tongue weight-care option? Tirzepatide is known for appetite regulation; this program explores an under-the-tongue format. A clinician reviews your goals, the formula and individual suitability.
From $259.00 /mo equivalent
$777.00 prepaid for 3 months
Medication, shipping, clinician review and ongoing support included.
Renews automatically. Cancel anytime in the portal or email hello@consideritrx.com.
Continue to the secure intake form. An independent clinician reviews your history before any prescribing decision.
Your program, considered
Tirzepatide is known for appetite and blood-sugar regulation. This compounded TirzeMelt orally disintegrating tablet is supplied for sublingual use.
Injection trials do not establish equivalent absorption, safety or weight-loss benefits for this sublingual formula. It is not FDA-approved.
See the research & risksClear pricing
Review the medication and strength choices. Your clinician confirms whether treatment fits before any prescription.
| Medication / strength | One-month total | Three-month total |
|---|---|---|
| TirzeMelt 4 mgCompounded dissolving tablet · Epiq | $349.0030-day total | $777.00$259.00/month equivalent · 90-day total prepaid |
| TirzeMelt 6 mgCompounded dissolving tablet · Epiq | $349.0030-day total | $777.00$259.00/month equivalent · 90-day total prepaid |
| TirzeMelt 10 mgCompounded dissolving tablet · Epiq | $349.0030-day total | $777.00$259.00/month equivalent · 90-day total prepaid |
| TirzeMelt 20 mgCompounded dissolving tablet · Epiq | $349.0030-day total | $785.79$261.93/month equivalent · 90-day total prepaid |
Care that considers you
Share your health history, medicines and goals in the secure intake form.
A licensed clinician reviews the evidence, risks and alternatives with you.
If prescribed, confirm the exact formula, directions, full cost and follow-up.
The details that matter
Know the evidence.
Make an informed decision.
It can reduce hunger and food intake. It also helps the body release insulin when blood sugar is high and slows how fast the stomach empties.
The linked trials studied specific approved injectable products. They do not establish equivalent absorption, safety or weight-management outcomes for this proposed sublingual formula.
Human trial · 2022
SURMOUNT-1 found greater weight loss with weekly tirzepatide than placebo in adults with obesity, or excess weight plus a health condition, without diabetes. Both groups received lifestyle support. The trial did not test CIRx compounded or oral forms.
Human trial · Published 2025
The trial followed adults with obesity and prediabetes for 176 weeks. Type 2 diabetes developed in 1.3% taking the drug versus 13.3% taking placebo. It tested weekly shots. The result does not prove benefits for microdoses, sprays, or under-the-tongue forms.
Study results are not a promise of personal results. Research on one formula or route does not establish the same results for another.
This proposed compounded sublingual formulation is not FDA-approved. The pharmacy formulation and availability are awaiting confirmation. The final pharmacy formulation or source remains pending confirmation.
Nausea, vomiting, diarrhea, and constipation are common. Severe belly pain, dehydration, or an allergic reaction needs prompt care. Do not use for weight loss during pregnancy or with certain thyroid cancer histories. Starting or increasing a dose can make birth-control pills less reliable. Ask about backup protection.
Compounded means a pharmacy makes a custom formula; compounded medicines are not FDA-approved. Off-label means a medicine is used in a way its FDA approval does not cover. Your clinician explains the exact product, risks and alternatives before treatment.
Source-listed active ingredients: Tirzepatide. Final pharmacy formulation awaiting confirmation. Your dispensing pharmacy confirms the final prescription label and any inactive ingredients.
No. A different route and formulation need their own evidence. The clinical results of an approved injection cannot establish equivalent outcomes for this proposed product.
This program uses sublingual. Other formulations have their own program pages.
Follow the directions provided with your prescription. Your clinician and dispensing pharmacy confirm the dose, preparation, storage and follow-up. The product image is not a dosing guide.
You can start secure intake now. A licensed clinician reviews your health history, medicines and goals, then confirms whether treatment is appropriate.
This browsing page does not collect medical information. Share health details only in the secure care portal.
Your next chapter
Start with your goals. A licensed clinician helps you understand what fits.
SemaMelt is an Epiq compounded sublingual tablet. Compare one-month plans and clinician-approved three-month maintenance at a fixed strength. Start, restart and dose changes require provider confirmation.
Medication, shipping, clinician review and ongoing support included.
Explore program
Make your weight goals part of a clear care plan. Zepbound® is a tirzepatide injection used to reduce excess weight and help maintain weight loss in eligible patients. A clinician reviews your health history, eligibility and treatment options.
Medication, shipping, clinician review and ongoing support included.
Explore program
Make your weight goals part of a clear care plan. Wegovy® is a semaglutide injection used to reduce excess weight and help maintain weight loss in eligible patients. A clinician reviews your health history, eligibility and treatment options.
Medication, shipping, clinician review and ongoing support included.
Explore program